AI assistant
Sending…
BIOGEN INC. — Director's Dealing 2017
Feb 1, 2017
30291_dirs_2017-02-01_bfe0bb47-0632-4fdd-beb5-80189a095a23.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Bioverativ Inc. (BIVV)
CIK: 0001681689
Period of Report: 2017-02-01
Reporting Person: BIOGEN INC. (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-02-01 | Common Stock | J | 107975968 | — | Disposed | 0 | Direct |
Footnotes
F1: Biogen Inc. distributed the shares to its shareholders on a pro rata basis in connection with the separation of the Issuer from Biogen Inc. on February 1, 2017.
F2: On January 31, 2017, the 1,000 shares of common stock of the Issuer, issued and outstanding as of such date, were reclassified and subdivided into 107,975,968 shares resulting in the reporting person's ownership of a total of 107,975,968 shares of common stock.
More from BIOGEN INC.
Regulatory Filings
2026
May 14
Major Shareholding Notification
2026
May 6
Major Shareholding Notification
2026
Apr 29
Interim / Quarterly Report
2026
Apr 29
Regulatory Filings
2026
Apr 29
Annual Report
2026
Apr 28
Proxy Solicitation & Information Statement
2026
Apr 28
Proxy Solicitation & Information Statement
2026
Apr 28
Major Shareholding Notification
2026
Apr 7
Regulatory Filings
2026
Apr 6